James P. Haire
@Brave Asset Management Inc
Latest period2024 - Q4ReportedManaged Assets$315.063MTotal holdings163
Assets growth rate-23.51%Assets growth rate (2-Q avg)-9.29%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Brave Asset Management Inc's 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 163 positions.
Assets under management
The assets under management (AUM) of Brave Asset Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 315.063M in assets, with a quarterly growth rate of -23.51% and a 2-quarter average growth rate of -9.29%. The portfolio is managed by James P. Haire, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BNDVanguard Bd Index Fds
| 0.13% | $397,950 5,534 shares@ $71.92 avg price | Increased 4.11% |
CRSPCrispr Therapeutics Ag
| 0.13% | $395,922↑ Call 10,059 shares@ $39.36 avg price | Increased 33.08% |
INTCIntel Corp
| 0.13% | $381,892↑ Call 19,047 shares@ $20.05 avg price | Increased 60.06% |
OXYOccidental Pete Corp
| 0.11% | $322,351 6,524 shares@ $49.42 avg price | Increased 50.88% |
NFLXNetflix Inc
| 0.11% | $319,093 358 shares@ $891.33 avg price | Increased 8.82% |
PYPLPaypal Hldgs Inc
| 0.08% | $241,370 2,828 shares@ $85.36 avg price | Increased 5.25% |
XRXXerox Holdings Corp
| 0.03% | $86,281 10,235 shares@ $8.43 avg price | Increased 0.75% |
RXRXRecursion Pharmaceuticals In
| 0.03% | $77,287 11,433 shares@ $6.76 avg price | Increased 14.34% |